Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
Condition:   Healthy VolunteersIntervention:   Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)Completed - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2010 Category: Research Source Type: clinical trials

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With HIV-1 Infection
Conditions:   H1N1 Influenza Virus;   Human Immunodeficiency Virus Type 1 (HIV-1) InfectionInterventions:   Biological: Focetria®;   Biological: Begrivac®Sponsors:   Chiltern Pesquisa Clinica Ltda;   Chiltern Pesquisa Clinica LtdaCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2009 Category: Research Source Type: clinical trials

Evaluation of Pandemic Vaccination Campaign
Condition:   Influenza Caused by the Novel A(H1N1)v Influenza VirusIntervention:   Other: Follow-upSponsor:   National Institute for Health and Welfare, FinlandCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2009 Category: Research Source Type: clinical trials